- Home
- VSEE vs BOLT Comparison
VSEE vs BOLT Comparison
Compare VSEE & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSEE
- BOLT
- Stock Information
- Founded
- VSEE 2008
- BOLT 2015
- Country
- VSEE United States
- BOLT United States
- Employees
- VSEE N/A
- BOLT N/A
- Industry
- VSEE
- BOLT Biotechnology: Pharmaceutical Preparations
- Sector
- VSEE
- BOLT Health Care
- Exchange
- VSEE NYSE
- BOLT Nasdaq
- Market Cap
- VSEE 25.1M
- BOLT 25.3M
- IPO Year
- VSEE N/A
- BOLT 2021
- Fundamental
- Price
- VSEE $1.38
- BOLT $0.52
- Analyst Decision
- VSEE
- BOLT Hold
- Analyst Count
- VSEE 0
- BOLT 5
- Target Price
- VSEE N/A
- BOLT $1.25
- AVG Volume (30 Days)
- VSEE 5.9M
- BOLT 168.8K
- Earning Date
- VSEE 02-15-2025
- BOLT 11-12-2024
- Dividend Yield
- VSEE N/A
- BOLT N/A
- EPS Growth
- VSEE N/A
- BOLT N/A
- EPS
- VSEE N/A
- BOLT N/A
- Revenue
- VSEE $8,064,925.00
- BOLT $9,779,000.00
- Revenue This Year
- VSEE N/A
- BOLT $9.87
- Revenue Next Year
- VSEE N/A
- BOLT N/A
- P/E Ratio
- VSEE N/A
- BOLT N/A
- Revenue Growth
- VSEE 37.45
- BOLT 35.86
- 52 Week Low
- VSEE $1.12
- BOLT $0.50
- 52 Week High
- VSEE $33.08
- BOLT $1.56
- Technical
- Relative Strength Index (RSI)
- VSEE N/A
- BOLT 38.20
- Support Level
- VSEE N/A
- BOLT $0.50
- Resistance Level
- VSEE N/A
- BOLT $0.59
- Average True Range (ATR)
- VSEE 0.00
- BOLT 0.03
- MACD
- VSEE 0.00
- BOLT -0.00
- Stochastic Oscillator
- VSEE 0.00
- BOLT 24.49
About VSEE VSEE HEALTH INC
VSee Health Inc is a telehealth software platform. VSee's telemedicine solution, offering a fast, secure text + video collaboration app HIPAA messenger, and fully customizable virtual waiting rooms and clinics, is a complete telehealth platform that fits into any workflow. The VSee proprietary technology platform and modular software solution enable users to plug and play telehealth services with end-to-end encrypted video streaming integrated with patient metrics, electronic medical records, and other sensitive data, with multiple other interactive functionalities. The company's products include VSee Clinic, VSee Messenger, VSee APIs, VSee Remote patient monitoring, VSee Telehealth Staffing.
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.